Fresenius Kabi Compounding, LLC recalls acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Ba
Recalled February 18, 2026 · FDA recall D-0333-2026 · Fresenius Kabi Compounding
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
1057 bags
Sold at
US Nationwide.
Description
Lack of Assurance of Sterility
Product
acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
Manufacturer(s)
Fresenius Kabi Compounding, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →